Trial Profile
Phase II Clinical Trial to Investigate the Efficacy, Safety and Pharmacokinetics of YH14617 After Once Weekly or Biweekly Administration in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Yuhan
- 17 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2014 Planned End Date changed from 1 Jul 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 26 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.